{
  "drug_name": "Molnupiravir",
  "url": "https://wikem.org/wiki/Molnupiravir",
  "scraped_at": "2026-01-10T07:57:36.137601",
  "sections": {
    "Administration": {
      "text": "Type:\nDosage Forms:\nRoutes of Administration:\nCommon Trade Names:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "COVID": {
          "text": "800 mg q12hr x 5d\nAges 18 and older only, mild to moderate disease only\nWithin 5 days of symptom onset",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "COVID": {
      "text": "800 mg q12hr x 5d\nAges 18 and older only, mild to moderate disease only\nWithin 5 days of symptom onset",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "Avoid in pregnant or young patients given concern for mutagenicity",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "Avoid in pregnant or young patients given concern for mutagenicity",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "",
      "subsections": {
        "Renal_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "Adult:\nPediatric:",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Adult:\nPediatric:",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Adult:\nPediatric:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life:\nMetabolism:\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Comments": {
      "text": "Phase 3 trial showed 30% reduction in risk of hospitalization or death",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}